双氢青蒿素在兽医临床的最新研究进展OA

As the core derivative of artemisinin,dihydroartemisinin(DHA)has increasingly prominent application value in veterinary clinical practice,thanks to its unique peroxide bridge structure,excellent pharmacological activity,and low toxicity to animals.In recent years,remarkable breakthroughs have been achieved in the fields of animal parasitic disease prevention and control,animal anti-tumor therapy,and autoimmune disease treatment in animals.Its advantages of"multi-target mechanism of action"and"host safety"have made it a key candidate drug for solving the problem of veterinary drug resistance and expanding therapeutic approaches.Focusing on the"cross-disease application advantages and mechanism innovation",this paper combs the research achievements of DHA in veterinary clinical practice,analyzes the bottlenecks,and prospects the development directions,so as to provide references for clinical transformation.